vial was initially stored in the refrigerator on 12-Jan-2023, the vials should have been discarded on 11Feb2023, the vaccine was given on 14-Feb-2023; No adverse event; The vials should have been discarded on 11-Feb-2023. She confirmed 8 doses were given after 11-Feb-2023, dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11-Feb-2023. She confirmed 8 doses were given after 11-Feb-2023, dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12-Jan-2023, the vials should have been discarded on 11Feb2023, the vaccine was given on 14-Feb-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 14-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11-Feb-2023. She confirmed 8 doses were given after 11-Feb-2023, dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12-Jan-2023, the vials should have been discarded on 11Feb2023, the vaccine was given on 14-Feb-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11-Feb-2023. She confirmed 8 doses were given after 11-Feb-2023, dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12-Jan-2023, the vials should have been discarded on 11Feb2023, the vaccine was given on 14-Feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11-Feb-2023. She confirmed 8 doses were given after 11-Feb-2023, dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12-Jan-2023, the vials should have been discarded on 11Feb2023, the vaccine was given on 14-Feb-2023).    No concomitant drug was reported. The vial was initially stored in refrigerator on 12-Jan-2023, the vaccine was administered on 14-Feb-2023.  The vial size was unknown. The nurse was asking about shelf-life for bivalent vaccine stored in the fridge.  It was reported that vial did not undergo any temperature excursions. No treatment drug was reported. This case contains information for the 3rd of 8 patients described by the reporter.    This case was linked to US-MODERNATX, INC.-MOD-2023-713727, US-MODERNATX, INC.-MOD-2023-713733, US-MODERNATX, INC.-MOD-2023-713729, US-MODERNATX, INC.-MOD-2023-713734, US-MODERNATX, INC.-MOD-2023-713735, US-MODERNATX, INC.-MOD-2023-713732, US-MODERNATX, INC.-MOD-2023-713736 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713727:Master Case US-MODERNATX, INC.-MOD-2023-713733: US-MODERNATX, INC.-MOD-2023-713729: US-MODERNATX, INC.-MOD-2023-713734: US-MODERNATX, INC.-MOD-2023-713735: US-MODERNATX, INC.-MOD-2023-713732: US-MODERNATX, INC.-MOD-2023-713736: